ATOVAQUONE-PROGUANIL EXPOSURE IN PREGNANCY AND RISK FOR ADVERSE FETAL AND INFANT OUTCOMES

被引:0
|
作者
Gutman, Julie R. [1 ]
Hall, Clinton [2 ,3 ]
Khodr, Zeina G. [2 ,3 ]
Bukowinski, Anna T. [2 ,3 ]
Gumbs, Gia R. [2 ,3 ]
Conlin, Ava Marie S. [2 ,4 ]
Wells, Natalie Y. [2 ]
Tan, Kathrine R. [1 ]
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA USA
[2] Naval Hlth Res Ctr, Deployment Hlth Res Dept, San Diego, CA USA
[3] Leidos Inc, San Diego, CA USA
[4] Innovat Employee Solut, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
50
引用
收藏
页码:16 / 16
页数:1
相关论文
共 50 条
  • [1] Atovaquone-proguanil exposure in pregnancy and risk for adverse fetal and infant outcomes: A retrospective analysis
    Gutman, Julie R.
    Hall, Clinton
    Khodr, Zeina G.
    Bukowinski, Anna T.
    Gumbs, Gia R.
    Conlin, Ava Marie S.
    Wells, Natalie Y.
    Tan, Kathrine R.
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2019, 32
  • [2] A survey on outcomes of accidental atovaquone-proguanil exposure in pregnancy
    Tan, Kathrine R.
    Fairley, Jessica K.
    Wang, Mengxi
    Gutman, Julie R.
    MALARIA JOURNAL, 2018, 17
  • [3] Safety of atovaquone-proguanil during pregnancy
    Mayer, Romana C.
    Tan, Kathrine R.
    Gutman, Julie R.
    JOURNAL OF TRAVEL MEDICINE, 2019, 26 (04)
  • [4] Atovaquone-Proguanil Use in Early Pregnancy and the Risk of Birth Defects
    Pasternak, Bjorn
    Hviid, Anders
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (03) : 259 - 260
  • [5] Atovaquone-proguanil exposure in pregnancy should not be condemned from current evidence
    Behrens, Ron
    Edwards, Phil
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 34
  • [6] A survey on outcomes of accidental atovaquone–proguanil exposure in pregnancy
    Kathrine R. Tan
    Jessica K. Fairley
    Mengxi Wang
    Julie R. Gutman
    Malaria Journal, 17
  • [7] Response to Behrens and Edwards: Atovaquone-proguanil exposure in pregnancy should not be condemned from current evidence
    Gutman, Julie R.
    Tan, Kathrine R.
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 34
  • [8] The safety of atovaquone-proguanil for the prevention and treatment of malaria in pregnancy: A systematic review
    Andrejko, Kristin L.
    Mayer, Romana C.
    Kovacs, Stephanie
    Slutsker, Emma
    Bartlett, Emily
    Tan, Kathrine R.
    Gutman, Julie R.
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2019, 27 : 20 - 26
  • [9] Pregnancy Outcome after first Trimester Exposure to Malarone (Atovaquone-Proguanil): A Prospective Case-Series
    Reuvers, N.
    Vial, T.
    Schaefer, C.
    Elefant, E.
    De Santis, M.
    Malm, H.
    Wentges-Van Holthe, N.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2012, 94 (05) : 329 - 329
  • [10] Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes
    Pasternak, Bjorn
    Svanstrom, Henrik
    Hviid, Anders
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (09) : 814 - 823